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ABSTRACT 
 
The physiological effect of high flow nasal cannula (HFNC) therapy is presumed to be a 
decrease in work of breathing (WOB) through an offloading of the diaphragm during 
inspiration with an increased expiratory resistance and accompanying positive end-expiratory 
pressure (PEEP) during expiration.  To determine whether this can be assessed objectively 
using a signal of the electrical activity of the diaphragm, measurements were taken off and 
then on HFNC, delivered at 2L/kg/min, in infants with (Bronchiolitis) and without (Cardiac) 
obstructive airways disease, and compared with other traditional measures of WOB.   
The electrical activity of the diaphragm (Edi) was measured using an Edi catheter and 
analysed for determinants of respiratory drive (signal peak EdiMAX and amplitude EdiAMPL).  
Respiratory Inductance Plethysmography (RIP) was analysed for changes in end-expiratory 
lung volume (RIPMIN) and a phase angle (θ) of thoraco-abdominal asynchrony (TAA), 
calculated using the Lissajous Loop Analysis (LLA) method.  Traditional WOB 
measurements, Pressure-Rate Product (PRP) and Pressure-Time Product (PTP) were 
calculated from analyses of oesophageal pressure (Poe).   
While the electrical activity of the diaphragm was higher in infants with Bronchiolitis 
than in Cardiac infants, significant decreases in respiratory drive (EdiMAX, EdiAMPL) were 
observed in both groups (p<0.05).  Infants with Bronchiolitis showed a significant increase in 
RIPMIN (p<0.05), while Cardiac infants showed a decrease in θ (p<0.05).  WOB decreased in 
both groups with a significant reduction of PRP and PTP (p<0.05).        
HFNC therapy, delivered at 2L/kg/min, offloads the diaphragm and is highly effective 
in reducing WOB in infants with Bronchiolitis.  Measurements of the electrical activity of the 
diaphragm provide a useful clinical tool for the objective assessment of WOB.  Changes in 
the electrical activity of the diaphragm are a more sensitive measure for detecting WOB 
changes compared with traditional measures of WOB.   
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1 INTRODUCTION 
This program of research forms part of a broader clinical study, investigating the impact of 
high flow nasal therapy on the work of breathing in infants with bronchiolitis, which was 
conducted by the Paediatric Critical Care Research Group (PCCRG), in the Paediatric 
Intensive Care Unit (PICU) of the Mater Children’s Hospital (MCH).  This chapter outlines 
the background of this broader clinical study to highlight the context, objectives and 
significance of this program of research.  A brief outline of the remaining chapters of this 
thesis is also provided. 
1.1 Background 
Bronchiolitis, with an underlying viral infection, is the most common cause of hospitalisation 
among infants in the first 12 months of life (Castro-Rodriguez, Rodriguez-Martinez et al. 
2015) and remains one of the main reasons for non-elective admissions to paediatric intensive 
care (Alexander, Millar et al. 2014).  Bronchiolitis is characterised by acute inflammation, 
oedema, and necrosis of the epithelial cells lining the small airways, and increased mucus 
production (Ralston, Lieberthal et al. 2014).  Among available treatment options, non-
invasive oxygen supplementation remains the mainstay of therapy (Ravaglia and Poletti 2014) 
(Da Dalt, Bressan et al. 2013).  Oxygen therapy, administered via a heated humidified high 
flow nasal cannula (HFNC) is a recently introduced form of non-invasive respiratory support 
(Spoletini, Alotaibi et al. 2015) (Mayfield, Jauncey-Cooke et al. 2014).  The use of HFNC is 
increasing across a range of patient groups, due to its ease of application, patient tolerance and 
observed clinical benefits (Hutchings, Hilliard et al. 2015) (Nishimura 2015) (Mayfield, 
Jauncey-Cooke et al. 2013) (McQueen, Rojas et al. 2014) (Milési, Boubal et al. 2014) 
(Manley, Dold et al. 2012).  In intensive care, retrospective studies have shown that HFNC 
can be applied safely and effectively, reducing intubation rates, in children less than two years 
of age with bronchiolitis (Schibler, Pham et al. 2011) (McKiernan, Chua et al. 2010) .  
However, despite the increasing use of HFNC therapy in the treatment of infants with 
Bronchiolitis (Da Dalt, Bressan et al. 2013) (Hutchings, Hilliard et al. 2015), the predominant 
mechanism of action of HFNC is not well established (Dysart, Miller et al. 2009).  Previous 
studies have investigated the postulated mechanisms of action of HFNC in relation to positive 
pressure generation (Sinha, McBride et al. 2015) (Spoletini, Alotaibi et al. 2015), often in 
comparison with other non-invasive ventilation devices (Wilkinson, Andersen et al. 2016) 
(Kotecha, Adappa et al. 2015) (Lavizzari, Veneroni et al. 2014) (de Jongh, Locke et al. 2014), 
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but its impact on the work and breathing pattern of infants with Bronchiolitis remains unclear 
(Rubin, Ghuman et al. 2014) (Lee, Rehder et al. 2013).   
1.2 Context 
Since interventions to improve patient outcomes are dependent on available assessment 
methods, it is desirable to have an economical and minimally invasive or non-invasive 
method for assessing the work of breathing (WOB) in infants and children admitted to 
intensive care.  Previously, WOB has been described in terms of the body’s oxygen cost of 
breathing of the muscles involved in respiration (Collett, Perry et al. 1985), measured in 
Joules/Litre (Diehl, Mercat et al. 2003) or mL O2/minute (Jones, Dean et al. 2003).  However, 
methods for determining metabolic consumption are difficult and unsuitable in an intensive 
care setting (Collett and Engel 1986) (Cala, Wilcox et al. 1991).  In the absence of robust 
measurement techniques, the determination of respiratory distress includes indicators for 
WOB and is commonly assessed with clinical scoring systems which are subjective and based 
on the clinical experience of the observer (Brochard, Martin et al. 2012) (Fallot 2005) (Rödl, 
Resch et al. 2012) (Gemke, van Keulen et al. 2005).  Traditional methods, such as Lissajous 
Loop Analysis (LLA) calculations for the measurement of Thoraco-Abdominal Asynchrony 
(TAA), can be used as an indication of respiratory distress (Hammer and Eber 2005), and 
derived calculations, such as the Pressure-Rate Product (PRP), can be used as surrogate 
measures of WOB (Collett, Perry et al. 1985).  However, these techniques do not measure 
WOB directly and are susceptible to disturbances from the measurement environment.  
Measurements of the electrical activity of the diaphragm (Edi) provide a more direct method 
for determining WOB and response to treatment from individual patients (Bellani, Mauri et 
al. 2013) (Ducharme-Crevier, Du Pont-Thibodeau et al. 2013).   
The Edi signal, a signal arising from the diaphragm’s neural activation during 
spontaneous breathing, is a validated measure of global respiratory drive (Sinderby, Beck et 
al. 1998) (Beck, Sinderby et al. 1998) and is currently used in mechanical ventilation systems 
to deliver respiratory support in both invasive (INV) and non-invasive ventilation (NIV) 
modes (Beck, Emeriaud et al. 2015).  Neurally adjusted ventilatory assist (NAVA) is a new 
mode of closed-loop mechanical ventilation which delivers airway pressure in proportion to 
the Edi signal (Ververidis, Van Gils et al. 2011).  As with other closed-loop controlled 
mechanical ventilation systems, ventilator variables required for the delivery of ventilator-
triggered mandatory breaths, are automatically manipulated based on the continuous 
measurement of respiratory parameters from the patient (Suarez-Sipmann 2014).  However, 
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these closed-loop ventilatory modes still require clinicians to specify individualised pressure 
limits, volume targets and proportionality constants to deliver appropriate levels of respiratory 
support for mandatory breaths (Fernández, Miguelena et al. 2013).  In intensive care, 
mechanical ventilation is only one potential intervention and little investigation has been 
conducted in to the potential use of an Edi signal as a controlling signal for other respiratory 
interventions, such as HFNC, where patients do not require the delivery of mandatory breaths.     
1.3 Purposes 
When used in conjunction with other physiological measurements, an Edi signal may be used 
as part of a more holistic approach for diagnostic WOB assessments and for the development 
of a patient-driven controlling mechanism for the delivery of HFNC as a main respiratory 
support mode.  It was the objective of a broader clinical study to investigate the impact of 
HFNC on WOB, in infants with Bronchiolitis, using Edi measurements.  The aim of this 
program of research is to determine the relationship between Edi measurements and other 
measurements known to correlate with WOB, in assessing WOB under HFNC and non-
HFNC conditions.  Specifically, using Edi measurements in conjunction with measurements 
of Respiratory Inductance Plethysmography (RIP) and oesophageal pressure (Poe), the 
objectives of this work are: 
 To quantify the peak (EdiMAX), magnitude (EdiAMPL) and area under the curve (EdiAUC) 
of the Edi signal under HFNC and non-HFNC conditions, and 
 To validate these results with calculations of TAA (using the LLA method), PRP and 
the diaphragmatic Pressure-Time Product (PTP(di)) 
1.4 Significance 
Closed-loop controlled mechanical ventilation modes, such as NAVA, have the advantage of 
monitoring and incorporating both ventilator and respiratory parameters to deliver ventilator-
triggered breaths that are more closely aligned with the natural breath-to-breath variability of 
a patient’s spontaneous breathing pattern (Suarez-Sipmann 2014).  However, current HFNC 
systems do not have such mechanisms in place to automatically adjust flow rates to meet the 
patient’s inspiratory demand.  At present, HFNC flow rates are manually set, as per 
recommended device guidelines, by clinicians based on a patient’s age and weight (Long, 
Babl et al. 2016) (Riese, Fierce et al. 2015) (Sotello, Orellana-Barrios et al. 2015) (Milési, 
Boubal et al. 2014).  While previous studies have attempted to develop formulas for 
determining ideal HFNC flow rates (Manley, Dold et al. 2012), to optimise respiratory 
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support and minimise WOB, further evidence is still needed and dose-finding studies have 
been suggested to further inform clinical practice.  Examining the characteristics of the Edi 
signal under HFNC and non-HFNC conditions would be the first step to developing an 
integrated control mechanism for the effective delivery of HFNC therapy.  Findings from the 
broader clinical study, from which this program of research is based, are the first published 
results describing Edi measurements under HFNC conditions in children under two years of 
age. This thesis details the specific work conducted to quantify characteristics of Edi signals, 
under HFNC and non-HFNC conditions, for the purposes of assessing WOB and validates the 
results against previously established methods for the calculation of WOB.  
1.5 Thesis Outline 
Chapter 2 contains a literature review of Edi signals, the mechanisms of action of HFNC and 
the previously established methods for calculating WOB.  Chapter 3 outlines the 
measurement set-up used for the data acquisition of physiological signals and the rationale for 
each measurement type.  Chapter 4 outlines the pertinent results of the broader clinical study 
which were achieved in relation to the objectives of this program of research.  Finally, 
Chapter 5 contains a discussion of the findings of this program of research as well as insights 
in to future research directions in this area.   
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2 LITERATURE REVIEW 
This chapter describes the current role of the Edi signal in mechanical ventilation, particularly 
in relation to the ventilatory mode of NAVA ventilation, and continues with a discussion of 
its emerging role as a monitoring technology for assessing diaphragmatic work (Section 2.1).  
This is followed by a discussion of the mechanisms of action of HFNC (Section 2.2) and 
previously established methods for calculating the WOB under these conditions (Section 2.3).    
2.1 NAVA and the Electrical Activity of the Diaphragm 
Regarding conventional mechanical ventilation (CMV), it has been shown that even relatively 
brief periods of controlled CMV can induce ventilator induced diaphragmatic dysfunction 
(Vassilakopoulos and Petrof 2004).  During assisted breathing, equally timed breaths of equal 
volume are provided, and a patient’s WOB is reduced when inspiratory flow from the 
ventilator exceeds the patient’s flow demand.  However, patients, particularly those with 
acute respiratory failure, often have unstable breathing patterns and their requirements for 
inspiratory flow may change from breath to breath (Kallet, Campbell et al. 2000).  
Accordingly, new forms of partial mechanical assistance have emerged, where the ventilator 
contribution is triggered by the patient’s respiratory muscles or inspiratory effort, to generate 
the ventilatory output.  Ideally, the respiratory muscles should be active enough to avert the 
risk of ventilator-induced diaphragmatic dysfunction, and the respiratory rhythm should be 
under the control of the patient’s respiratory centres.  Partial mechanical ventilation is aimed 
to avoid excessive support and guarantee persistent diaphragm activity, enhance patient–
ventilation interaction and synchrony, and facilitate the natural breath-to-breath variability, 
while maintaining adequate gas exchange and optimal patient comfort.  The effort exerted by 
the respiratory muscles directly (as with neurally adjusted ventilatory assist ventilation) or 
indirectly (as with proportional assist ventilation) drives and regulates ventilator functioning 
(Terzi and Navalesi 2014).   
NAVA is a mode of ventilation whereby the timing and amount of ventilatory 
assistance is controlled by the patient's neural respiratory drive.  In NAVA, the inspiratory 
assistance is proportional to Edi, which corresponds to muscle fibres depolarization, occurring 
immediately after the output of the central respiratory centres and just before the intrathoracic 
pressure variations induced by muscle contraction (Gottfried, Friberg et al. 1999).  Using the 
Edi as the controller signal, NAVA is able to deliver synchronized assistance, both invasively 
and non- invasively (NIV-NAVA), to follow the variability in breathing pattern, and to 
monitor patient respiratory drive, independent of leaks.  NIV- NAVA, in particular, provides 
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a truly synchronized mode of non-invasive ventilation, both in time and in level of assistance, 
and can increase a clinician’s ability to treat respiratory failure non-invasively (Sinderby and 
Beck 2013).  Compared with CMV, NAVA results in improved patient-ventilator interaction 
and synchrony, increased breath-to-breath mechanical variability, enhanced oxygenation and 
provides lower peak inspiratory pressure, with some evidence suggesting improved patient 
comfort, less sedation with reduced ventilatory drive, and reduced length of stay (Beck, 
Emeriaud et al. 2015) (Kallio, Peltoniemi et al. 2015) (Baudin, Pouyau et al. 2015) (Bellani, 
Coppadoro et al. 2014) (Vagheggini, Mazzoleni et al. 2013) (de la Oliva, Schüffelmann et al. 
2012). 
Previously, techniques for assessing diaphragmatic work, utilising measurements of 
trans-diaphragmatic pressure and abdominal volume displacement, have shown inspiratory 
work to be strongly correlated with the electrical activity of the diaphragm, as measured from 
its moving average (Guslits, Gaston et al. 1987).  The monitoring of Edi is a new minimally 
invasive bedside technology that was developed for the NAVA mode of ventilation.  In 
addition to its role in NAVA ventilation, this technology provides the clinician with 
previously unavailable and essential information on diaphragm activity.  It allows ventilatory 
settings to be tailored on an individual basis, avoiding over-assistance, potentially leading to 
diaphragmatic atrophy.  Increased inspiratory Edi levels can also suggest insufficient support, 
while a strong tonic activity may reflect the patient efforts to increase their lung volume 
(Larouche, Massicotte et al. 2015).  Edi monitoring can play a role in the evaluation of 
extubation readiness (Wolf, Walsh et al. 2011). Further, Edi monitoring provides the clinician 
with better understanding of the ventilatory capacity of patients with acute neuromuscular 
disease (Ducharme-Crevier, Du Pont-Thibodeau et al. 2013).  Since infants and young 
children are predominantly dependent on their diaphragms for respiration, it follows that a 
signal of the electrical activity of the diaphragm may be used to measure WOB during HFNC 
treatment and to assess the impact of HFNC on patients and their response to therapy.   
2.2 Mechanisms of Action of HFNC 
Originally seen as an alternative respiratory support to nasal continuous positive airway 
pressure (CPAP) for preterm infants, the effectiveness of HFNC has been predominantly 
studied in this context (Dani, Pratesi et al. 2009) (Saslow, Aghai et al. 2006).  Studies 
comparing HFNC against other oxygen delivery methods such as face mask oxygen, standard 
nasal cannula, CPAP and other positive pressure devices have been conducted (Bell, 
Hutchinson et al. 2015) (ten Brink, Duke et al. 2013) (Chang, Cox et al. 2011).  However, 
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unlike traditional NIV devices which use variable flows to generate a fixed CPAP, HFNC 
systems maintain a fixed flow and generate variable pressures which are not easily monitored 
(Hasan and Habib 2011).  It is proposed that HFNC reduces WOB and improves ventilation 
efficiency through the following mechanisms of action: (1) washout of the nasopharyngeal 
dead space, (2) reduction of upper airway resistance, (3) improvement in conductance and 
pulmonary compliance, (4) reduction in the metabolic work of gas conditioning, and (5) the 
provision of positive airway pressure (Dysart, Miller et al. 2009).   
HFNC systems deliver a heated, humidified oxygen-air mixture at flow rates that may 
meet or exceed a patient’s spontaneous inspiratory flow rate.  In infants, flow rates are 
dependent on the age and weight of the child.  Clearing of the nasopharyngeal cavity with 
flow rates that match or exceed inspiratory demand allows for better consistency in arterial 
oxygen saturation (SaO2), improved carbon dioxide (CO2) clearance and ventilation 
efficiency.  The provision of gas which is pre-heated to body temperature and humidified to 
100% relative humidity, reduces the metabolic work associated with gas conditioning, as 
performed by the nasopharynx under normal respiration.  Further, improvements in 
pulmonary compliance and conductance have been demonstrated (Saslow, Aghai et al. 2006) 
in contrast with the delivery of gas which is not warmed or humidified (Greenspan, Wolfson 
et al. 1991).  It is believed that the provision of positive distending pressure, or positive end-
expiratory pressure (PEEP), can result in improved ventilatory mechanics and assist with gas 
exchange.  Previous studies have demonstrated increases in nasal pharyngeal pressures, oral 
cavity pressures, end-expiratory oesophageal pressures and tracheal pressures (Groves and 
Tobin 2007) (Lampland, Plumm et al. 2009) (Kubicka, Limauro et al. 2008) (Parke, 
McGuinness et al. 2009).  However, despite a direct relationship between pharyngeal and 
airway pressures with increasing flow (Urbano, del Castillo et al. 2012), the degree of positive 
pressure generated remains inconsistent and can be affected by factors such as the presence of 
leak around the nares and mouth opening (Hasan and Habib 2011).  Regardless of differences 
in oesophageal pressure, HFNC has a similar effect to CPAP in reducing inspiratory airway 
resistance through the nasopharynx, which can contribute substantially to WOB.  By 
delivering gas flows that match or exceed a patient’s peak inspiratory flow, HFNC minimises 
this inspiratory resistance by stenting the airways, decreasing the resistive WOB.  However, 
unlike CPAP, HFNC differs during the expiratory phase with increased expiratory pressure 
serving as a means to increase resistance to expiratory air.  For most patients, the generation 
of positive airway pressure is less likely to be the predominant factor in relieving respiratory 
distress (Lee, Rehder et al. 2013).  The mechanisms of action of HFNC appear to be through 
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improvements in inspiratory air-flow dynamics and increases in expiratory resistance 
(Mundel, Feng et al. 2013).   
2.3 Determining the Work of Breathing 
It is well known that patients who experience less respiratory distress generally recover better 
overall (Banner, Kirby et al. 1994).  Reliable methods for assessing respiratory distress and 
WOB are essential in formulating appropriate treatments and monitoring response to therapy.  
Optimised respiratory support aims to reduce WOB by meeting a patient’s individual 
respiratory requirements to maximise their recovery effort while minimising their recovery 
time.  Previously, WOB has been described in terms of the body’s oxygen (O2) cost of 
breathing of the muscles involved in respiration (Collett, Perry et al. 1985).  However, 
methods for determining metabolic consumption are difficult and unsuitable in an intensive 
care setting (Cala, Wilcox et al. 1991).  Alternative methods, describing the muscle activity 
involved in respiration, have been developed.  In the absence of robust measurement 
techniques, the determination of respiratory distress includes observational indicators for 
WOB and is commonly assessed with clinical scoring systems which are generally subjective 
and based on the clinical experience of the observer (Bueno Campaña, Olivares Ortiz et al. 
2014) (Fallot 2005).  These indicators may include visual observations of a patient’s physical 
movement of breathing (muscle use, nasal flaring etc.), colour, irritability, feeding and 
fatigue.  Broad states of WOB (usually mild, moderate and severe) are defined, but do not 
include quantifiable methods of distinguishing WOB levels or established links to commonly 
monitored physiological parameters (Ravaglia and Poletti 2014).  
Thoraco-Abdominal Asynchrony is descriptive of and referred to in clinical scoring 
systems as chest wall retractions, an observable WOB criterion.  It is expressed as a phase 
angle (θ) of the non-coincident movement of the rib-cage (RC) and abdomen (ABD) during 
breathing (Hammer and Newth 2009) (Hammer and Eber 2005) and can be used as an 
indicator of respiratory distress.  TAA can be measured non-invasively using Respiratory 
Inductance Plethysmography, a technique traditionally used in sleep laboratories to describe 
thoracic and abdominal movements (Reiterer, Sivieri et al. 2015).  The technique requires a 
period of restful breathing for measurement calibration and accuracy is usually only achieved 
while a subject remains in a single postural position.  RIP measurements may be analysed for 
TAA using the Lissajous Loop Analysis method which is an examination of the loops created 
by plotting the RC and ABD excursions as an X-Y plot.  In normal full-term infants, the RC 
and ABD expand in synchrony, producing a closed or very narrow loop with a positive slope.  
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During TAA, the loop opens and may become progressively wider as TAA increases.  
Paradoxical breathing also creates a closed or very narrow loop, but with a negative slope.  
Further, the direction of loop rotation indicates which compartment (RC or ABD) precedes 
the other.  Anti-clockwise loops indicate that the ABD compartment (diaphragm) leads the 
RC, as usually observed in normal quiet breathing and most forms of respiratory distress in 
children  (Hammer and Eber 2005).  The LLA method assumes that the RC and ABD signals 
are sinusoidal.  In addition to the LLA method, RIP may be analysed and used to measure 
tidal volume (VT) and end-expiratory levels (EEL) and for estimates of respiratory mechanics 
and WOB (Courtney, Aghai et al. 2003) (Pandit, Courtney et al. 2001) (Saslow, Aghai et al. 
2006) (Lavizzari, Veneroni et al. 2014) (Itagaki, Okuda et al. 2014).  However, while 
increasing TAA mirrors the physiological effect on the infant that increasing respiratory loads 
cause, it does not detect respiratory muscle fatigue.   
When respiratory muscles contract, the chest wall expands to produce a pressure 
difference which allows air to be drawn in to the lungs.  Pleural pressures inside the chest wall 
may be estimated with measurements of oesophageal pressure and calculations derived from 
these measurements may be used as surrogate measures of WOB (Sassoon, Light et al. 1991).  
Inspiratory WOB is calculated from the curve of oesophageal pressure versus tidal volume 
and can be computed using a Campbell diagram.  However, this method may underestimate 
WOB at higher rates of ventilation compared with estimates developed from tracings of the 
RC and ABD (Goldman, Grimby et al. 1976).  Pressure-Time Product (PTP) can be used to 
measure inspiratory muscle load and is regarded as an index of the oxygen cost of breathing 
of the respiratory muscles as well as WOB.  PTP is calculated as the area subtended by the 
Poe tracing and the chest wall static recoil pressure for inspiratory time (Sassoon, Light et al. 
1991).  However, it requires an accurate knowledge of inspiratory flow which cannot be 
measured with HFNC therapy or in infants and children without an artificial airway.  The 
technique can be modified for non-intubated infants where PTP(mod) is calculated using the 
maximum negative deflection of Poe and inspiratory time recorded from a RIP device.  A 
further modification allows for the calculation of WOB in both intubated and non-intubated 
infants to be measured using changes in Poe (pleural pressure) and respiratory rate (RR).  The 
resultant calculation is a Pressure-Time Index (PTI) which is also more accurately referred to 
as the Pressure-Rate Product.  PTI or PRP is an estimate of the energy cost of the WOB 
because oxygen consumption by muscle is proportional to the integral of muscle tension (or 
pressure) with respect to time (Klein and Reynolds 1986).  Since it is independent of volume 
related measurements it has the advantage of measuring the work imposed and is a useful 
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measure in situations where there is a disconnection between respiratory effort and volume 
(Brochard, Martin et al. 2012).  However, as PRP uses an unintegrated pressure signal, it may 
still underestimate the true WOB.  Further, this method of assessing WOB does not account 
for the added load when intercostal muscle activity is lost and rib cage distortion occurs.  It is 
suggested that the PTI of the diaphragm is a parameter which reflects most of the O2 
consumed by the respiratory muscles during loaded breathing (Collett, Perry et al. 1985) and 
that PTP(di) is a valid measure of diaphragm unloading, where flow is constant (Fauroux, 
Hart et al. 2003). 
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3 METHODS 
This chapter describes the measurement methodology which was utilised as part of the 
broader clinical study, from which this program of research is based.  A background to the 
methodology of the broader clinical study is included in Appendix A.1.  Detailed descriptions 
of the data acquisition components (Figure 1 and Section 3.1) and analysis methods (Section 
3.2) adopted to achieve the objectives of this program of research, are presented in this 
chapter. 
 
 
Figure 1: Conceptualised equipment set-up and connection diagram for the broader clinical study from which 
this program of research is based.  Data acquisition techniques used, were for: the electrical activity of the 
diaphragm, Respiratory Inductance Plethysmography, oesophageal pressure, and Electrial Impedance 
Tomography. 
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3.1 Materials and Measurements  
3.1.1 HFNC Device 
As per standard practice at the primary study site of the broader clinical study, infants were 
fitted with the appropriate sized nasal cannula (Optiflow Junior Nasal Cannula, Fisher & 
Paykel Healthcare, Auckland, New Zealand) and the flow rate was commenced through a 
HFNC circuit (Optiflow Junior RT330, Fisher & Paykel Healthcare, Auckland, New Zealand) 
at 2L/kg/min (Figure 2).  The fraction of inspired oxygen (FiO2) was titrated to maintain 
peripheral oxygen saturation (SpO2) values between 94-98%, and the humidifier was set at 
37ºC (MR850, Fisher & Paykel Healthcare, Auckland, New Zealand).  For all measurements, 
mouth closure was obtained either spontaneously or with a pacifier.  
 
 
Figure 2: An illustration of the standard High Flow Nasal Cannula system, used in the broader clinical study 
from which this program of research is based, manufactured by Fisher & Paykel Healthcare.  
(https://www.fphcare.com.au) 
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3.1.2 Electrical Activity of the Diaphragm 
The Edi signal was measured using an appropriate sized Edi catheter, a nasogastric probe 
designed for use with the NAVA module of a Servo-i ventilator (Maquet Critical Care, Solna, 
Sweden).  The Edi catheter was inserted through the nose, to the level of the diaphragm, and 
the non-inserted portion was taped to the side of the patient’s face to ensure stability of probe 
placement.  When positioned correctly, the neural excitation of the diaphragm is captured by 
an array of electrodes fitted at the end of the Edi catheter, is filtered and processed by the 
NAVA module and then relayed to the Servo-i ventilator (Figure 3).  For the Edi signal to be 
recorded simultaneously with other data signals for analysis, the resultant Edi signal from the 
Servo-i Ventilator was then fed to a laptop computer running ventilator performance data 
software (Servo Tracker v4.1, Maquet Critical Care, Solna, Sweden) and then on to a 
PowerLab 16/35 Series analogue recording device (ADInstruments Ltd, Dunedin, New 
Zealand) via the use of a USB 6229 BNC communications module (National Instruments 
Corporation, Texas, USA).  The Edi signal was examined for determinants of respiratory 
drive where increased diaphragm activity is indicated by increased values of EdiMAX and 
EdiAMPL.   
 
 
Figure 3: An illustration of the Edi monitoring function of a Servo-i ventilator, manufactured by MAQUET, 
which was used in isolation to monitor the Edi signal of patients receiving High Flow Nasal Cannula therapy.  
(http://www.maquet.com) 
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3.1.3 Respiratory Inductance Plethysmography 
A respiratory inductance plethysmograph, Respitrace Q.D.C. (CareFusion Corporation, San 
Diego, USA), with self-calibration functionality was used to determine respiratory movement 
and asynchrony.  Two separate bands, XactTrace Disposable Belts (Embla, Denver, USA), 
were placed; one around the chest circumference between the armpits and nipple level and 
one around the abdomen at navel level (Figure 4).  For consistency, measurements were taken 
with infants lying in the supine position.  Physiological data generated by the RIP are 
waveforms representative of the RC, ABD and overall respiratory (SUM) movement.  The 
RIPSUM signal was used as the main respiratory waveform in subsequent analyses and the 
RIPRC and RIPABD signals were used in the calculation of θ for TAA, using the LLA method.  
These RIP signals were fed directly from the Respitrace Q.D.C. to the PowerLab device via 
BNC cables.   
 
 
Figure 4: An illustration of the placement of disposable bands used in the measurement of Respiratory 
Inductance Plethysmography (http://www.mortara.com/au). 
3.1.4 Oesophagus Pressures 
Poe measurements were taken as an indirect measure of CPAP.  The Edi catheter, which has a 
side port used for nasogastric tube (NG) feeds, was connected to a pressure transducer and 
pulled back to the distal third of the oesophagus to achieve a waveform that was free from 
cardiac artefact. Feeds were discontinued for the length of the study. To maintain patency of 
the Edi catheter, a normal saline flush at a rate of 1mL/hr was applied. The Poe signal was fed 
into the PowerLab device and then calibrated and zeroed to atmospheric pressure.  The Poe 
signal was used in conjunction with the RIPSUM signal for calculations of PRP and PTP(di) as 
well as the intrinsic Positive End-Expiratory Pressure (PEEPi).       
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3.1.5 Electrical Impedance Tomography 
As with other clinical studies, previously conducted by the investigators of the broader 
clinical study, a Goe-MF II Electrical Impedance Tomography (EIT) system (Cardinal Health, 
Hoechberg, Germany) was used as a non-invasive monitoring tool to examine the regional 
ventilation distribution and regional filling characteristics of the lungs (Schibler, Yuill et al. 
2009, Grant, Pham et al. 2011, Humphreys, Pham et al. 2011, Pham, Yuill et al. 2011, Hough, 
Johnston et al. 2012, Schibler, Pham et al. 2013, Hough, Pham et al. 2014).  Sixteen 
electrocardiography (ECG) electrodes were placed equidistantly around the chest 
circumference, at nipple level, and a 75 kHz injection frequency of 5mApk-pk was used to 
produce functional images of relative impedance changes at a rate of 13 images per second 
(13 Hz) (Figure 5).  Due to the complexity and limitations of the EIT system, measurements 
were recorded on to a separate EIT-dedicated laptop computer.  However, to synchronise the 
EIT recordings with the rest of the study measurements, a 1.5 V marker signal was applied to 
both the sole analogue channel of the EIT system as well as to one of the available channels 
on the PowerLab device via BNC cables.  All EIT measurements were recorded with infants 
lying in the supine position. 
 
 
Figure 5: An illustration of the ECG electrode placement used in the measurement of Electrical Impedance 
Tomography (Frerichs, Hinz et al. 2002). 
3.1.6 Data Acquisition using PowerLab 
All waveforms channelled in to the PowerLab device were recorded using the accompanying 
data acquisition and analysis software, LabChart v6.1 (ADInstruments Ltd, Dunedin, New 
Zealand).  All PowerLab signals were sampled at 1 kHz. 
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3.2 Measurement Analysis 
As per the design of the broader clinical study (Appendix A.1), a treatment (Bronchiolitis) 
group and control (Cardiac) group of infants, with and without clinical signs of increased 
WOB respectively, were measured off and on HFNC therapy.  For each change in HFNC 
state, a period of 5 minutes was allowed for stabilisation and data was recorded for 10 
minutes to capture periods of undisturbed regular breathing for analysis.  In accordance with 
analysis conventions set by the investigators of the broader clinical study, waveform segments 
of at least ten contiguous breaths, with little variation in segment baseline and breath-to-
breath amplitude (Frerichs, Schiffmann et al. 2003), were identified at the end of each set of 
measurements and used for analysis as follows.   
3.2.1 Edi, RIPSUM and Poe 
Basic parameters such as the breath-to-breath minimum, maximum, amplitude, rate, and area 
under the curve (AUC) were calculated.  These parameters, as calculated for the Edi signal, 
were: the end-expiratory level Edi (EdiMIN), the inspiratory maximum Edi (EdiMAX), Edi 
amplitude (EdiAMPL), breath-to-breath respiratory rate Edi (EdiRR) and breath-to-breath Edi 
AUC (EdiAUC).   
Similar parameters, calculated for the overall respiratory movement (RIPSUM) signal, 
were: the end-expiratory level (RIPMIN, also referred to as RIPEEL), the inspiratory peak 
(RIPMAX), amplitude of tidal breathing (RIPAMPL), breath-to-breath respiratory rate (RIPRR) 
and breath-to-breath AUC (RIPAUC).  Additional RIPSUM parameters calculated were: the 
inspiratory time to peak (RIPTi), the respiratory cycle length (RIPTtot), and the ratio between 
the inspiratory-phase to length of entire respiratory cycle (RIPTi/Ttot).   
Parameters calculated for the Poe signal were: the minimum respiratory Poe point 
(PoeMIN), the maximum respiratory Poe point (PoeMAX), and the breath-to-breath change in 
Poe amplitude (PoeAMPL).   
3.2.2 Traditional WOB Calculations 
Traditional measures for assessing WOB were derived from the Poe and RIP signals (Figure 
6) (Pham, O'Malley et al. 2015).  The Pressure-Rate Product, which is often used as a 
simplified method of examining WOB, was calculated as PoeAMPL multiplied by RR (Klein 
and Reynolds 1986).  The Pressure-Time Product of the diaphragm was used to examine the 
inspiratory WOB and was calculated as the integral of the Poe curve during inspiration 
(∫PoeINSP) multiplied by RR (Collett, Perry et al. 1985). The intrinsic Positive End-Expiratory 
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Pressure was calculated as the difference between PoeMAX and the Poe at the start of 
inspiration, as defined by the RIPSUM signal i.e. the drop in Poe during the short time period 
when no inspiratory volume change on the RIPSUM signal could be observed (Collett, Perry et 
al. 1985).   
 
 
Figure 6:  Representative overall inspiratory RIPSUM and oesophageal pressure (Poe) waveforms with a signal 
showing the start of inspiration.  For each breath, the respiratory rate (RR) was determined from the total length 
of respiration as defined by the overall inspiratory waveform (RIPTtot).  The Pressure-Rate Product is calculated 
as the oesophageal pressure amplitude multiplied by the respiratory rate, PRP = PoeAMPL x RR.  The intrinsic 
Positive End-Expiratory Pressure (PEEPi) is defined as the difference between the maximum oesophageal 
pressure and the oesophageal pressure at the start of inspiration.  The diaphragmatic Pressure-Time Product is 
calculated as the area subtended by the oesophageal pressure waveform during inspiration (taking into account 
the PEEPi) multiplied by the respiratory rate, PTP(di) = ∫PoeINSP x RR.  The ratio of inspiratory time to total 
inspiratory time was determined from the overall inspiratory waveform, RIPTi/Ttot = RIPTi / RIPTtot.  (Pham, 
O'Malley et al. 2015) 
3.2.3 Lissajous Loop Analysis 
Thoraco-Abdominal Asynchrony is descriptive of chest wall retractions which are an 
observable WOB criteria included in clinical assessments for respiratory distress.  It is 
assessed using the Lissajous Loop Analysis method and is expressed as a phase angle, θ, of 
the non-coincident movement of the ribcage and abdomen (Prisk, Hammer et al. 2002).  
Specifically, from an X-Y plot of the RC and ABD excursions, θ is calculated as the arcsine 
of the distance traversed by the ABD at the mid-point of the overall RC excursion (m), 
divided by the overall ABD excursion (s) (Figure 7) (Hammer and Eber 2005).  However, 
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despite the range of commercial tools and modules available for data analysis, no specific 
tools exist for the performance of LLA analysis in LabChart.  Consequently, for this program 
of research, a specific series of LabChart macros were developed and implemented to perform 
the required phase angle analysis, using the LLA method.  For completeness, further data 
analysis macros were also developed using Visual Basic for Applications (VBA) in Microsoft 
Excel, to collate data and perform additional calculations.  Additional parameters, calculated 
during the step-wise implementation of the LLA method, were: the minimum RC point 
(RCMIN), the maximum RC point (RCMAX), the RC excursion length (RCAMPL), the minimum 
ABD point (ABDMIN), the maximum ABD point (ABDMAX), the ABD excursion length 
(ABDAMPL), the Area Inside the Loop and the Slope of the Loop. 
 
 
Figure 7:  The phase angle of TAA is calculated from the equation sin θ = m/s, where m is the distance traversed 
by the ABD at the mid-point of the RC excursion and s is the overall ABD excursion (Hammer and Eber 2005).  
3.2.4 EIT 
EIT measurements were analysed separately using an EIT Data Analyser program, previously 
developed by me, for the broader clinical study investigators, in MATLAB.  However, a 
subset of the pre-processed EIT waveforms was also up-sampled, synchronised, and input to 
LabChart for integrated analysis.  Namely, waveforms representative of the overall respiratory 
movement (EITGLOBAL), the anterior region of the lungs (EITANTERIOR) and the posterior 
regions of the lungs (EITPOSTERIOR) were analysed in LabChart, examining the breath-to-
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breath minimums, maximums and amplitudes of each signal.  For completeness, it is noted 
that EIT analysis methods, as standardised by the broader clinical study investigators, were 
written by me and includes examinations of regional end-expiratory level, regional tidal 
volume amplitudes, asynchrony between lung compartments (expressed as a Phase Angle, α), 
distribution profiles of relative impedance change, and calculations for the geometric centre of 
ventilation (GC), regional filling indices (FI) and the global inhomogeneity index (GI) 
(Schibler, Yuill et al. 2009, Grant, Pham et al. 2011, Humphreys, Pham et al. 2011, Pham, 
Yuill et al. 2011, Hough, Johnston et al. 2012, Schibler, Pham et al. 2013, Hough, Pham et al. 
2014).   
3.3 Implementation in LabChart 
For this program of research, the Edi, RIP, Poe and subset EIT signals were analysed using a 
specific sequence of LabChart and Excel based macros, developed by me.  A detailed 
description of the particular series of LabChart macros, incorporating the LLA method for 
calculating phase angles, is included in Appendix A.2.   
3.4 Statistics 
Unless otherwise stated, data is presented as a mean and 95% confidence interval (CI).  Paired 
samples t-Test was applied for parameters measured off and on HFNC therapy, for infants 
with Bronchiolitis (the treatment group) and Cardiac infants (the control group), and a 
univariate ANOVA was used to compare data between subgroups within each HFNC state 
(SPSS 15.0 for Windows).  A p-value of <0.05 was considered to be statistically significant.  
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4 RESULTS 
4.1 Electrical Activity of the Diaphragm 
 
Figure 8: Representative recording of the electrical activity of the diaphragm showing the effect of removing 
and reapplying HFNC therapy.   
 
 
Figure 9:  Mean values of the electrical activity of the diaphragm for infants with Bronchiolitis and Cardiac 
infants, off and on HFNC.  Mean and 95% confidence intervals are shown. 
 
Overall, the measured changes off and on HFNC in EdiMAX, EdiAMPL and EdiAUC were 
significantly higher in infants with Bronchiolitis compared to Cardiac infants, whereas the 
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measured changes in EdiMIN and EdiRR were not (Figure 9).  Within the group of infants with 
Bronchiolitis, significant decreases from off HFNC to on HFNC were observed in the EdiMIN, 
EdiMAX, EdiAMPL, EdiRR and EdiAUC.  Within the group of Cardiac infants, similar but less 
prominent changes in electrical diaphragmatic activity were observed (Table 1).  
 
Table 1:  Mean values and absolute mean changes of the electrical activity of the diaphragm for infants with 
Bronchiolitis and Cardiac infants, off and on HFNC.  Paired samples t-Tests were used to compare HFNC states 
within groups (*).  An ANOVA was used to compare mean changes between groups (^).  A p-value of <0.05 
was considered to be statistically significant.   
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
EdiMIN [µV] 
p-value 
2.798 
0.010* 
1.789 1.902 
0.004* 
1.156 1.009 
0.118 
0.746 
EdiMAX [µV] 
p-value 
27.879 
0.017* 
20.995 12.155 
<0.001* 
8.244 6.884 
<0.001^ 
3.911 
EdiAMPL [µV] 
p-value 
25.081 
0.021* 
19.206 10.253 
<0.001* 
7.088 5.875 
<0.001^ 
3.165 
EdiRR [BPM] 
p-value 
61.236 
0.003* 
55.275 52.325 
0.067 
44.483 5.961 
0.061 
7.842 
EdiAUC [µV.s] 
p-value 
13.453 
0.006* 
10.114 8.012 
0.001* 
5.956 3.339 
0.002^ 
2.056 
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4.2 Respiratory Inductance Plethysmography 
In comparing infants with Bronchiolitis to Cardiac infants, the measured changes off and on 
HFNC in RIPMIN, RIPMAX, RIPAMPL and RIPTi/Ttot were not significantly different (Figure 10).  
However, infants with Bronchiolitis showed a significant increase in end-expiratory level 
RIPMIN, between HFNC states whereas the group of Cardiac infants only showed a moderate 
but not significant increase. In infants with Bronchiolitis: a significant increase in RIPMIN and 
RIPAUC and a significant decrease in RIPMAX, RIPAMPL, RIPRR, and RIPTi/Ttot were observed 
from off HFNC to on HFNC. In the group of Cardiac infants, only the RIPAMPL and RIPTi/Ttot 
showed a significant decrease (Table 2).  
 
 
Figure 10:  Mean values of the overall Respiratory Inductance Plethysmography waveform (RIPSUM) for infants 
with Bronchiolitis and Cardiac infants, off and on HFNC.  Mean and 95% confidence intervals are shown. 
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Table 2:  Mean values and absolute mean changes in the Respiratory Inductance Plethysmography 
measurements taken for infants with Bronchiolitis and Cardiac infants, off and on HFNC.  Paired samples t-Tests 
were used to compare HFNC states within groups (*).  An ANOVA was used to compare mean changes between 
groups (^).  A p-value of <0.05 was considered to be statistically significant.   
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
RIPMIN [V] 
p-value 
2.341 
0.012* 
2.413 2.368 
0.113 
2.391 0.072 
0.905 
0.023 
RIPMAX [V] 
p-value 
2.793 
0.046* 
2.745 2.768 
0.149 
2.742 0.048 
0.689 
0.026 
RIPAMPL [V] 
p-value 
0.452 
0.017* 
0.332 0.399 
0.025* 
0.350 0.120 
0.729 
0.049 
RIPRR [BPM] 
p-value 
59.584 
0.004* 
53.513 47.547 
0.084 
41.101 6.071 
0.008^ 
6.446 
RIPAUC [V.s] 
p-value 
2.635 
0.003* 
2.977 3.951 
0.059 
4.591 0.342 
0.001^ 
0.640 
RIPTi [ms] 
p-value 
528.988 
0.125 
564.095 806.719 
0.428 
824.912 35.107 
0.015^ 
18.193 
RIPTtot [ms] 
p-value 
947.507 
0.006* 
1076.245 1387.971 
0.073 
1579.446 128.738 
0.005^ 
191.475 
RIPTi/Ttot [0-1] 
p-value 
0.559 
0.025* 
0.522 0.572 
0.017* 
0.521 0.037 
0.829 
0.051 
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4.3 Oesophagus Pressure 
Between infants with Bronchiolitis and Cardiac infants, the measured changes off and on 
HFNC in PoeMIN, PoeMAX, PoeAMPL and PEEPi were not significantly different, whereas 
changes in the traditional measures of WOB, PRP and PTP(di), were (Figure 11).  In infants 
with Bronchiolitis, PoeMIN increased from off HFNC to on HFNC, PoeMAX remained 
relatively similar, and PoeAMPL decreased. Similarly, in Cardiac infants, PoeMIN increased, 
PoeMAX remained unchanged and PoeAMPL decreased. For traditional measures of WOB, the 
PRP and PTP(di) decreased significantly in infants with Bronchiolitis. In Cardiac infants, 
similar but less prominent changes were observed. With both groups, PEEPi decreased from 
off HFNC to on HFNC (Table 3).   
 
 
Figure 11:  Mean values in the Oesophageal Pressure waveform and related WOB calculations for infants with 
Bronchiolitis and Cardiac infants, off and on HFNC.  Mean and 95% confidence intervals are shown. 
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Table 3:  Mean values and absolute mean changes of the oesophageal pressure calculations for infants with 
Bronchiolitis and Cardiac infants, off and on HFNC.  Paired samples t-Tests were used to compare HFNC states 
within groups (*).  An ANOVA was used to compare mean changes between groups (^).  A p-value of <0.05 
was considered to be statistically significant.   
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
PoeMIN [cmH2O] 
p-value 
-9.936 
0.001* 
-5.727 -8.036 
0.040* 
-5.236 4.209 
0.393 
2.800 
PoeMAX [cmH2O] 
p-value 
5.379 
0.266 
4.667 3.095 
0.495 
3.104 0.712 
0.172 
0.009 
PoeAMPL [cmH2O] 
p-value 
15.315 
0.001* 
10.393 11.131 
0.039* 
8.340 4.922 
0.078 
2.791 
PRP [cmH2O/min] 
p-value 
969.647 
0.004* 
598.450 540.726 
0.074 
302.679 371.197 
0.007^ 
238.047 
PTP [cmH2O.s/min] 
p-value 
228.302 
0.003* 
148.896 124.825 
0.046* 
82.311 79.406 
0.006^ 
42.514 
PEEPi [cmH2O] 
p-value 
5.573 
0.032* 
3.206 4.230 
0.112 
2.651 2.367 
0.399 
1.579 
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4.4 Lissajous Loop Analysis 
 
(a) A Bronchiolitis infant, off and on HFNC. 
 
 
(b) A Cardiac Infant, off and on HFNC 
 
Figure 12:  Representative Lissajous Loops of the rib cage and abdomen signals on an X-Y plot, taken from 
Respiratory Inductance Plethysmography recordings, for an infant with Bronchiolitis and a Cardiac infant, off 
and on HFNC. 
 
In calculating the phase angle of TAA using the LLA method, a number of step-wise 
calculations were conducted and additional waveform parameters examined.  However, 
between infants with Bronchiolitis and Cardiac infants, no significant differences in the 
measured changes off and on HFNC were found (Table 4).  In infants with Bronchiolitis, 
RCMAX and RCAMPL decreased from off HFNC to on HFNC.  The calculated phase angle also 
decreased from off HFNC to on HFNC but the finding was not statistically significant.  In 
Cardiac infants, RCMIN increased while RCAMPL and the distance traversed by the ABD signal 
at the mid-point of the RC excursion decreased.  It is of note that θ also decreased from off 
HFNC to on HFNC (Figure 13).   
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Table 4:  Mean values and absolute mean changes of the Lissajous Loop Analysis related calculations for infants 
with Bronchiolitis and Cardiac infants, off and on HFNC.  Paired samples t-Tests were used to compare HFNC 
states within groups (*).  An ANOVA was used to compare mean changes between groups (^).  A p-value of 
<0.05 was considered to be statistically significant.   
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
RCMIN [V] 
p-value 
2.368 
0.066 
2.410 2.373 
0.021* 
2.411 0.042 
0.884 
0.038 
RCMAX [V] 
p-value 
2.694 
0.029* 
2.653 2.651 
0.136 
2.633 0.041 
0.320 
0.018 
RCAMPL [V] 
p-value 
0.326 
0.044* 
0.242 0.278 
0.009* 
0.222 0.084 
0.459 
0.056 
ABDMIN [V] 
p-value 
2.430 
0.100 
2.445 2.435 
0.252 
2.441 0.015 
0.931 
0.006 
ABDMAX [V] 
p-value 
2.636 
0.332 
2.649 2.683 
0.126 
2.631 0.013 
0.622 
0.052 
ABDAMPL [V] 
p-value 
0.207 
0.468 
0.204 0.248 
0.088 
0.191 0.003 
0.666 
0.057 
m [V] 
p-value 
0.143 
0.160 
0.119 0.169 
0.018* 
0.087 0.024 
0.910 
0.082 
s [V] 
p-value 
0.207 
0.468 
0.204 0.248 
0.088 
0.191 0.003 
0.666 
0.057 
Area Inside Loop 
p-value 
0.025 
0.227 
0.021 0.030 
0.117 
0.020 0.004 
0.763 
0.010 
Slope 
p-value 
1.360 
0.155 
0.454 0.844 
0.201 
1.205 0.906 
0.789 
0.361 
θ [°] 
p-value 
56.038 
0.200 
44.229 63.493 
0.007* 
27.395 11.809 
0.689 
36.098 
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Figure 13:  Mean values of the Lissajous Loop Analysis related calculations for infants with Bronchiolitis and 
Cardiac infants, off and on HFNC.  Mean and 95% confidence intervals are shown. 
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4.5 Electrical Impedance Tomography 
EIT analysis, as standardised by the investigators of the broader clinical study, was conducted 
separately.  Since EIT is a monitoring technology used primarily to describe ventilation 
distribution and lung mechanics, and not for describing indicators associated with WOB, the 
main results of this analysis are presented in Appendix A.3.  However, for completeness, 
results from the subset of pre-processed EIT signals, which were included with the main 
LabChart analysis, are presented below (Table 5).   
 
Table 5:  Mean values and absolute mean changes in the pre-processed Electrical Impedance Tomography 
waveforms1 for infants with Bronchiolitis and Cardiac infants, off and on HFNC.  Paired samples t-Tests were 
used to compare HFNC states within groups (*).  An ANOVA was used to compare mean changes between 
groups (^).  A p-value of <0.05 was considered to be statistically significant.   
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
GMIN [∆Z] 
p-value 
-0.017 
0.065 
0.003 0.002 
0.103 
0.013 0.020 
0.198 
0.011 
GMAX [∆Z] 
p-value 
0.016 
0.157 
0.030 0.047 
0.213 
0.055 0.014 
0.014^ 
0.008 
GAMPL [∆Z] 
p-value 
0.033 
0.034* 
0.027 0.045 
0.265 
0.042 0.006 
0.036^ 
0.003 
AMIN [∆Z] 
p-value 
-0.019 
0.063 
0.008 -0.023 
0.002* 
0.006 0.027 
0.806 
0.029 
AMAX [∆Z] 
p-value 
0.012 
0.142 
0.033 0.019 
0.003* 
0.045 0.021 
0.419 
0.026 
AAMPL [∆Z] 
p-value 
0.030 
0.043* 
0.024 0.042 
0.246 
0.039 0.006 
0.069 
0.003 
PMIN [∆Z] 
p-value 
-0.023 
0.141 
-0.005 0.021 
0.464 
0.022 0.018 
0.019^ 
0.001 
PMAX [∆Z] 
p-value 
0.019 
0.295 
0.028 0.070 
0.403 
0.067 0.009 
0.008^ 
0.003 
PAMPL [∆Z] 
p-value 
0.042 
0.013* 
0.034 0.049 
0.199 
0.045 0.008 
0.202 
0.004 
1 Pre-processed Electrical Impedance Tomography waveforms, representative of the Global (G), Anterior (A) and Posterior (P) regions of the 
lungs, were examined for minima (GMIN, AMIN, PMIN), maxima (GMAX, AMAX, PMAX) and amplitude values (GAMPL, AAMPL, PAMPL). 
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Figure 14: Representative Electrical Impedance Tomography recordings showing the effect of removing and 
reapplying HFNC therapy.  The EIT Analog Channel signal was used as a marker signal to indicate specific 
changes in HFNC states and provided a means of synchronising these recordings with other signals recorded in 
LabChart.  
 
(a) (b)  
 
Figure 15: Representative Electrical Impedance Tomography images showing ventilation distribution (a) off 
HFNC and (b) on HFNC therapy.   Relative impedance changes (∆Z) increased with the application of HFNC 
therapy. 
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4.6 Publications 
Significant clinical findings from this program of research were accepted for publication in 
the journal of Pediatric Pulmonology.   The paper, titled “The effect of high flow nasal 
cannula therapy on the work of breathing in infants with Bronchiolitis”, was published online 
(Epub ahead of print) in mid-2014 before appearing in print in mid-2015 (Pediatric 
Pulmonology 2015; 50: 713-720) (Pham, O'Malley et al. 2015).  A second publication, 
describing the specific calculation steps for examining TAA using the LLA method in 
LabChart, is currently in planning.  Further work regarding the Edi signal is also in discussion 
with the investigators of the broader clinical study from which this program of research is 
based.   
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5 DISCUSSION 
To contextualise the research findings, the results must be discussed in terms of the clinical 
significance to the broader clinical study, from which this program of research is based.  A 
summary of specific findings, in relation to the clinical WOB scoring component of the 
broader clinical study, is presented in Appendix A.4.  
5.1 WOB Measurements and Assessments 
5.1.1 Electrical Activity of the Diaphragm 
Since the diaphragm is a muscle whose effort is modulated by the number of activated muscle 
fibres, a reduction in a signal of the electrical activity of the diaphragm would imply a 
decrease in oxygen consumption by the respiratory system and the postulated offloading of 
the diaphragm could be demonstrated with an Edi signal.  It is notable that infants with 
Bronchiolitis showed greater baseline Edi values compared to the group of Cardiac infants, a 
finding which is consistent with the observed Edi values of patients with respiratory diseases 
(Emeriaud, Larouche et al. 2014).  Overall, infants with Bronchiolitis showed average 
inspiratory drive values (EdiMAX and EdiAMPL) >25μV off HFNC therapy while Cardiac 
infants showed values <15μV.  Normal values for EdiMAX have been reported to be between 
10 and 15μV.  It has been demonstrated that changes in the tonic activity of the diaphragm are 
associated with changes in end-expiratory lung volume (EELV) and that persistent 
diaphragmatic activity during the expiratory phase helps to regulate EELV (Emeriaud, Beck 
et al. 2006) (Lopes, Muller et al. 1981).  Again, in infants with Bronchiolitis, indicators of the 
tonic activation of the diaphragm at end-expiration, EdiMIN, were also consistently higher 
compared to those of the Cardiac infants.  As expected, the effect of HFNC on WOB had the 
greatest overall impact in the group of infants with Bronchiolitis, as measured with Edi.  
However, it is interesting to note that significant changes were also detectable, off HFNC to 
on HFNC, in the group of Cardiac infants where the measured values were generally smaller. 
5.1.2 Respiratory Inductance Plethysmography 
In comparison with Edi, similar changes in the indicators for respiratory drive (RIPMAX and 
RIPAMPL) and EELV (RIPMIN) were also measured with RIP.  However, RIP measurements 
were only sensitive enough to detect most of the significant changes in the group of infants 
with Bronchiolitis.  In particular, an increase in RIPMIN was congruent with a decrease in 
EdiMIN, indicating that less work was required for the maintenance of EELV.  Bodily 
responses to the electrical signals emitted from the neural centres, to drive respiration, will 
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depend on the disease state and mechanics of the respiratory muscles.  Unlike infants with 
Bronchiolitis, Cardiac infants did not require a lot of respiratory support off HFNC.  For 
Cardiac infants, a reduction in WOB was detected with the application of HFNC, but no 
clinically relevant changes in respiratory support were actuated.    
5.1.3 Oesophageal Pressure 
An examination of the oesophageal pressure waveforms yielded similar findings to the RIP 
and Edi measurements.  For both groups, the added respiratory support provided by HFNC 
resulted in a decrease in PoeAMPL which was consistent with the decrease in RIPAMPL.  With 
the onset of inspiration, any observed drop in mediastinal pressure (Poe) without an observed 
volume change is equivalent to the PEEPi.  With HFNC therapy, PEEPi was reduced, 
indicating the CPAP effect of HFNC in lessening small airway obstruction.  However, as with 
the EELV results between infants with Bronchiolitis and Cardiac infants, changes in PEEPi as 
well as the traditional WOB measurement, PRP, were only significant for infants with 
Bronchiolitis.  Again, while the Cardiac group showed a slight reduction in WOB, the impact 
on Poe did not reveal a clinically significant improvement in PEEPi or PRP with the 
application of HFNC.  The PTP(di) is a calculation which considers the effort of the 
diaphragm.  PTP quantifies inspiratory effort, giving a good indication of the energy 
expenditure of the respiratory muscles and has been used to estimate the metabolic cost of 
breathing.  As was demonstrated with the Edi signal, PTP(di) was able to detect a reduction in 
WOB for both groups, regardless of the scale of measured values off and on HFNC.   
5.1.4 LLA for TAA 
An increase in RCMIN and ABDMIN was consistent with an increase in EELV on HFNC.  For 
both groups, a significant increase in RCAMPL with an accompanying decrease in ABDAMPL 
indicated an increase in respiratory support with less respiratory drive from the diaphragm.  
These results strengthen and support the previous findings of the Edi, RIP and Poe.  However, 
Cardiac infants showed a better response to HFNC than infants with Bronchiolitis when 
respiratory distress was examined using the LLA method.  Phase angles are elevated in cases 
of acute upper airway obstruction.  Reductions are consistent with changes in the degree of 
stridor and are accompanied by improvements in inspiratory flows and tidal volumes 
(Hammer and Eber 2005).  However, despite indications of improved respiratory support, the 
calculated phase angle, θ, was only shown to be significant in the group of Cardiac infants.  In 
these infants, the width of the LLA loop became narrower on HFNC and similar but not 
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significant changes could be observed in infants with Bronchiolitis.  Since changes could be 
detected in a group without obstructive airway disease (Cardiac infants), the results suggest 
further investigation in to the adequacy of HFNC delivery rates, particularly for infants with 
Bronchiolitis, could be needed. 
5.2 WOB Measures for HFNC 
For this program of research, LabChart-based macro tools were developed to assist clinicians 
with the analysis of RIP signals using the LLA method.  However, for the purposes of bedside 
WOB assessments, the use of these tools may not be as time effective as the current method 
of clinical WOB scoring despite greater accuracy of assessment.  Studies comparing RIP 
against PRP found that PRP was a better discriminator of inspiratory load and respiratory 
support (Hammer and Eber 2005).  However, while both methods have been used 
successfully to measure different descriptors of respiratory effort, the results are still a 
secondary response to primary respiratory drive.  For instance, RIP examines the movement 
of the chest wall and abdomen, the control of which changes with maturation, and PRP 
utilises the respiratory rate as part of the calculation, a physiological parameter that also 
changes with age.  By comparison, the strength of the electrical activity of the diaphragm is 
independent of age, even in infants less than one year of age where there is greater prevalence 
in the tonic activation of the diaphragm during expiration.   
In this study, it was demonstrated that a signal of the electrical activity of the diaphragm 
was able to detect changes in WOB in infants on HFNC and that the Edi signal had a greater 
relationship with the measured changes than traditional measures of WOB.  Specifically, the 
measurement of EdiMAX, EdiAMPL and PTP(di) are promising objective measures for the 
assessment of WOB.  Previously, a similar scale of changes to those measured in these values, 
have been reported in clinically relevant parameters such as the respiratory rate and heart rate, 
in infants with Bronchiolitis, treated with HFNC therapy (Schibler, Pham et al. 2011).  As 
changes in these parameters correlate well with the degree of WOB observed clinically, they 
could potentially be used for the titration of flow rates in infants on HFNC.  These findings 
suggest that a “dose finding” study in HFNC could be undertaken using these physiological 
measurements as determinants of the efficacy of therapy.   
5.2.1 Clinical Significance of Research Findings 
The physiological effect of HFNC is presumed to be through an offloading of the diaphragm 
during inspiration with an increased expiratory resistance and accompanying PEEP during 
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expiration.  With the broader clinical study, the work of breathing in infants with 
Bronchiolitis was effectively reduced with the application of HFNC therapy, at a rate of 
2L/kg/min.  The results of this study showed a significant reduction in the measured electrical 
activity of the diaphragm and oesophageal pressure waveforms in these infants.  A similar but 
less prominent effect could also be demonstrated in the control group of Cardiac infants 
(without airway obstruction).  However, while it was expected that infants with Bronchiolitis 
would show a greater range of significant results across the measured parameters and 
calculations compared to the group of Cardiac infants, off and on HFNC therapy, this was not 
always the case.  Determining the optimal flow rate for specific patient groups with differing 
disease pathophysiology is still a topic of debate among clinicians and treating institutions.  
Patients enrolled in to the broader clinical study were treated with HFNC therapy at a flow 
rate of 2L/kg/min, in accordance with the clinical guidelines of the MCH PICU.  However, 
for some patients, this level of support may exceed their actual requirements while for 
patients who do not respond well to HFNC therapy, this level of support may be inadequate, 
requiring a clinical review for a higher rate of flow.  The effect of specific flow rates was not 
investigated as part of this program of research and further clinical trials are still needed to 
determine the safety and efficacies of higher flow rates in infants and children. 
5.2.2 Future Directions for WOB and HFNC Flow Rate Titration 
In other respiratory support modes, it has been reported that neurally triggered breaths reduce 
trigger delay, improves ventilator response times and may decrease the WOB in children with 
Bronchiolitis (Clement, Thurman et al. 2011). In particular, the feasibility and benefit of 
NAVA has been investigated in children with severe Respiratory Syncytial Virus (RSV) 
related Bronchiolitis where NAVA was found to provide a less aggressive ventilation, 
requiring lower inspiratory pressures with good results for oxygenation and more comfort for 
the children (Liet, Dejode et al. 2011).  However, mechanical ventilation and other forms of 
non-invasive ventilation may interfere with the spontaneous breathing pattern in infants 
because they have strong reflexes that play a large role in the control of breathing (Beck, 
Tucci et al. 2004).  With HFNC therapy, the delivery of flow rates which match the 
respiratory requirements of the patient on a breath-by-breath basis has yet to be explored and 
little evidence regarding weaning strategies currently exist (Farley, Hough et al. 2015).  Given 
the nature and sensitivity of the Edi signal in distinguishing WOB and monitoring respiratory 
drive, independent of age, further research in to the use of an Edi signal as a primary driving 
mechanism for delivering flow rates for HFNC should be considered for a future study.  Of 
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course, while commercial Edi catheters which can double as a nasogastric tube already exist, 
making them ideal for use in intensive care, the engineering challenge now would be to 
incorporate this technology in to existing bedside monitors in accost effective manner, 
making the Edi signal simple for routine use in infants.  In this way, further clinical research 
may then be conducted to determine whether using and responding to Edi measurements will 
make a difference to the outcomes for infants requiring HFNC or other forms of respiratory 
support.      
5.3 Limitations 
The main aim of the broader clinical study was to examine the impact of HFNC on WOB in 
infants with Bronchiolitis.  However, the study did not specifically address every postulated 
mechanism of action, which may have contributed to the efficacy of HFNC, as part of the 
investigation.  Instead, the study focused primarily on the response of the muscles involved 
with respiration, the resultant pressure generated within the chest and changes in 
physiological observations, with and without the application of HFNC.   Several measurement 
techniques and calculations were used to describe the impact of HFNC on WOB.  However, 
the sensitivity and specificity of these measurement techniques as predictors of clinical 
outcome were not investigated as part of the broader clinical study.  Further, only one flow 
rate was utilised as part of the investigation, which may not have provided the best result for 
all study participants. 
 In this small physiological study, a group of Cardiac infants were used as a control 
group to demonstrate the effectiveness of HFNC as a respiratory support mode between 
infants with and without small airways obstruction.  It is noted that these Cardiac infants 
would have experienced some physiological changes following their respective cardiac 
surgeries, and were not a strict group of representative “healthy” controls for respiratory 
comparisons per se.  However, these Cardiac infants were a demographically homogenous 
group with minimal respiratory complications, representing the most feasible and accessible 
cohort for comparison within the broader clinical study.  Overall, Cardiac infants showed 
consistent responses and slight improvements could be shown in some of the measured 
parameters and calculations for infants studied within this group.   
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5.4 Conclusion 
HFNC therapy, delivered at a rate of 2L/kg/min, is highly effective in reducing WOB in 
infants with Bronchiolitis and a similar physiological effect could be observed in infants 
without significant lung disease.  Measurements of the electrical activity of the diaphragm 
provided a useful clinical tool for the objective assessment of WOB and the efficacy of this 
non-invasive respiratory support mode.  By comparison, a signal of the electrical activity of 
the diaphragm was demonstrated to be more sensitive in the detection of WOB changes than 
traditional WOB assessment methods utilising oesophageal pressures or RIP.  However, for 
more comprehensive clinical assessments, measurements of oesophageal pressure and RIP 
may be used in conjunction with the electrical activity of the diaphragm for better establishing 
a patient’s disease state and their response to treatment. 
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APPENDICES 
 
A.1 Background to Methodology 
Given the clinical nature of the study objectives, a collaborative relationship with an 
established clinical research group was pertinent for the acquisition of relevant data for 
analysis.  In general, clinical research studies require Human Research Ethics Committee 
(HREC) clearance and Governance approval, sufficient funding, qualified trained staff and 
dedicated measurement equipment, before any data collection may commence.  At the time of 
project conception, the Paediatric Critical Care Research Group (PCCRG), affiliated with 
Mater Research, were in the early planning stages of conducting a study with similar 
objectives, in the Paediatric Intensive Care Unit (PICU) of the Mater Children’s Hospital 
(MCH), South Brisbane.  For this program of research, only access to previously collected 
and non-identifiable human data from the PCCRG was sought for analysis.  As such, this 
program of research was determined to be exempt from full ethical review and the appropriate 
approvals were sought and granted by the QUT HREC as well as the Mater Health Services 
(MHS) HREC and Governance authorisation body.  To adhere with ethical guidelines, no part 
of the PCCRG’s on-site data collection regime was completed by representatives of QUT.  
Instead, extensive consultation was given to the PCCRG regarding the data acquisition and 
data analysis components of their study, and only relevant non-identifiable human data was 
accessed and analysed for this program of research. 
A.1.1 The Clinical High Flow Work of Breathing Study 
Prior to the closure of the MCH in November 2014, the PCCRG conducted a prospective 
interventional trial in PICU - the clinical High Flow Work of Breathing (HFWOB) study - to 
examine the effect of High Flow Nasal Cannula (HFNC) therapy on the Work of Breathing 
(WOB) in infants and children with Bronchiolitis.  For their study, a group of infants and 
children with congenital heart disease (CHD) were used as a “control” group to compare 
differences between a cohort with (Bronchiolitis) small airways obstruction and a (Cardiac) 
group with no airway obstruction.  Inclusion criteria for the Bronchiolitis group were: (i) 
clinical diagnosis of Bronchiolitis with increased WOB on HFNC therapy, (ii) oxygen 
requirement on HFNC > 30%, (iii) aged 0-12 months, and (iv) PCR positive for one of the 
commonly tested respiratory viruses (Influenza A or B, Rhino/Enterovirus). In the Cardiac 
group, the inclusion criteria were: (i) oxygen requirement post-extubation, (ii) aged 0-12 
months, (iii) no clinical signs of increased WOB, and (iv) readiness to be discharged to a 
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regular paediatric ward.  Excluded were infants with an oxygen requirement > 60%, 
craniofacial malformations, upper airway obstruction and, in Cardiac patients, a clinically 
diagnosed increased WOB or diagnosed tracheomalacia.   
A.1.2 Study Design 
Eligible infants in both study groups were to be measured during two states: (a) off HFNC 
therapy, where 100% humidified and heated oxygen was delivered sub-nasally to maintain 
SpO2>92% and then (b) on HFNC therapy, which was delivered at 2L/kg/min.  Since all 
spontaneously breathing infants with Bronchiolitis, admitted to the MCH PICU, were treated 
with HFNC as per their standard hospital practice, patients enrolled in this group were taken 
off HFNC for the first set of measurements.  Following each change in HFNC state, whether 
on-off or off-on, a period of 5 minutes was allowed for stabilisation.  Data was then recorded 
for 10 minutes to capture periods of undisturbed regular breathing for analysis.   
In accordance with the HFWOB study objectives, a number of physiological waveforms 
and clinical observations were recorded.  These included: a signal of the electrical activity of 
the diaphragm (Edi); Respiratory Inductance Plethysmography (RIP), oesophageal pressure 
(Poe), Electrical Impedance Tomography (EIT) and clinical observations such as the 
respiratory rate, heart rate, fraction of inspired oxygen (FiO2) and peripheral oxygen 
saturations (SpO2).  Clinical WOB scoring was also performed by a dedicated senior research 
nurse for each study infant, off and on HFNC.  For this program of research, only relevant 
subsets of these measurements and observations were examined for performing WOB 
assessment calculations.     
A.1.3 Timeline for Completion 
As highlighted in Annual Progress Reports, a number of challenges and difficulties were 
experienced during this program of research.  Specifically, this program of research relied 
heavily on the accessibility of viable study data from the efforts of the PCCRG, and as such, 
project progression was highly dependent on the progress of the PCCRG in accomplishing 
their own clinical work.  Consequently, delays and difficulties experienced by the PCCRG 
with regard to their rate of patient recruitment, accuracy of data collection and documentation, 
management of staff turnover and funding had an impact on the timing of specific tasks for 
this program of research.  Delays in ethics and research governance approvals from the MHS 
HREC were also experienced during project set-up.  However, these were eventually 
resolved.     
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A.2 LabChart Analysis 
It may have been simpler to have performed all the required phase angle and other data 
analysis tasks for this study, using a software package such as MATLAB.  However, clinical 
research studies have limited funding and access to resources and, from a feasibility 
standpoint, any data acquisition and analysis approach must be translatable to clinical 
practice.  That is, the ideal solution should be one where clinicians can replicate the findings 
of their study with minimal access to specialist technical expertise which is not readily 
available outside of a research setting.  In light of these specifications, an integrated data 
analysis solution, developed in LabChart and Microsoft Excel, was the favoured approach for 
this program of research.   
A.2.1 Design Limitations and Restrictions 
LabChart has a limit of 32 channels for data acquisition and analysis.  In general, available 
channel calculations are dependent on specific software modules and extensions installed, and 
only one type of channel calculation may be output to a given channel at any one time.  When 
performing channel calculations, LabChart uses customisable cycle detection methods to 
identify waveform excursions and treats each cycle period identified as a complete signal for 
analysis.  A separate channel is used to output the result of each channel calculation.  The 
result channel is a “waveform” of values where the cycle length of each value corresponds to 
the respective cycle period from which the calculated value was obtained.  When specific 
results are compiled for export, channel values corresponding to a specific marker position 
within each previously detected cycle period are extracted and saved to an internal 
spreadsheet area (Data Pad).  By default, LabChart defines and detects cycle periods peak-to-
peak, and uses the first peak as the marker position for data extraction.  However, in a clinical 
context, data is conceptually more meaningful when examined trough-to-trough where the 
rising edge from the first trough is generally congruent with inspiration.  It is noted that even 
when the appropriate adjustments are made to the cycle detection settings, the manner in 
which LabChart constructs “result waveforms” and extracts channel values necessitates a 
carefully considered approach to ensure correct values are extracted for analysis.  A series of 
LabChart macros was developed to perform channel calculations as economically as possible.  
Further data analysis macros were then developed in Microsoft Excel to complete the required 
calculations, and to compile and collate the result data for statistical analysis. 
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A.2.2 Macro Sequences 
Four LabChart macros were primarily developed for analysing the signals collected from the 
clinical HFWOB study, from which this program of research is based, and a broad range of 
waveform parameters and related calculations were included in the implementation.   
The first LabChart macro was designed to determine the basic waveform parameters of 
the Edi signal and RIPSUM signal.  For these signals, the base “Cyclic Measurements” channel 
function was used to determine: EdiMIN, EdiMAX, EdiAMPL, EdiRR, EdiAUC, RIPMIN, RIPMAX, 
RIPAMPL, RIPRR and RIPAUC.  Additionally, for the RIPSUM signal, the “Peak Analysis” 
channel function was used to determine RIPTi, and RIPTtot, and channel arithmetic used to 
determine RIPTi/Ttot.  The marker position for data extraction was the start point of each 
detected cycle. 
The second LabChart macro was designed to aid in the calculation of phase angles 
using the LLA method.  To adequately examine the relationship between the RC and ABD 
signals, a waveform of unit spikes, based on a system definition of the start of inspiration 
(RIPSUM(InspUnitSpikes)), was generated and used to identify cycle periods for analysis.  A 
combination of “Cyclic Measurements” and arithmetic channel calculations were then used to 
determine: RCMAX, RCMIN, ABDMAX, and ABDMIN as well as the ABD values where RC 
crosses zero in the LLA loops.  A further sequence of arithmetic and “Cyclic Measurements” 
channel calculations were then performed to determine: the ABD loop excursion when RC is 
zero (m), the maximum ABD loop excursion (s), a phase angle (ɵ = arcsin(m/s)) between 0-
90 degrees, and values for Slope Direction and Loop Rotation.  The marker position for data 
extraction was the peak of each detected RIPSUM cycle.  To determine a clinically meaningful 
phase angle value, expressed between -180 to 180 degrees, the final phase angle calculation 
was performed during the data collation process using an Excel VBA Macro. 
The third LabChart macro was designed to determine the basic waveform parameters of 
the pre-processed EIT signals and Poe signal as well as a limited number of equivalent 
parameters for the RIPSUM, where available channels permitted.  For the pre-processed EIT 
signals, the base “Cyclic Measurements” channel function was used to determine: EITGLOBAL 
(AMPL), EITGLOBAL (MAX), EITGLOBAL (MIN), EITANTERIOR (APML), EITANTERIOR (MAX), EITANTERIOR 
(MIN), EITPOSTERIOR (AMPL), EITPOSTERIOR (MAX), and EITPOSTERIOR (MIN).  The marker position for 
data extraction was the start point of each detected cycle.  For the RIPSUM signal, the “Peak 
Analysis” channel function was used to determine: Baseline (RIPMIN), APeak (RIPMAX), 
Height (RIPAMPL), TimeToPeak (RIPTi) and Width (RIPTtot), and channel arithmetic used to 
determine RIPTi/Ttot.  For the Poe signal, a RIPSUM(InspUnitSpikes) signal (as described in the 
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second LabChart macro) was generated and applied before the base “Cyclic Measurements” 
channel function could be used to determine PoeMAX and PoeMIN, and channel arithmetic used 
to determine PoeAPML.  With the RIPSUM and Poe signals, the marker position for data 
extraction was the peak of each detected RIPSUM cycle. 
Through specific examination of the RIPSUM and Poe signals, the fourth LabChart 
macro was designed to perform related calculations for traditional measures of WOB: PRP, 
PTP(di) and PEEPi.  As with the second LabChart macro, a RIPSUM(InspUnitSpikes) signal was 
generated and used to identify cycle periods for analysis, and a corresponding waveform of 
the inspiratory duty cycle was also generated and used specifically in the calculation for 
PTP(di).  Following the application of the RIPSUM(InspUnitSpikes) signal, the base “Cyclic 
Measurements” channel function was used to determine: the respiratory rate (RIPRR), PoeMIN 
and PoeMAX, and channel arithmetic used to determine PoeAMPL.  A sequence of “Cyclic 
Measurements” and arithmetic operations were then used to determine: PEEPi, PRP and 
PTP(di), including ∫PoeINSP for each breath.  The marker position for data extraction was the 
peak of each detected RIPSUM cycle. 
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A.2.3 Example LabChart Waveform Recordings 
 
 
Figure 16: Representative LabChart recording of the RC, ABD, RIPSUM and Edi signals of an infant on HFNC 
delivered at 2L/kg/min.  In this example, no Poe signal was recorded (red line in the fourth channel).  Instead, a 
trigger signal was attached to the Poe Channel to aid in later analysis. 
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Figure 17: Representative LabChart recording of the RC, ABD, RIPSUM and Poe signals of an infant on HFNC 
delivered at 2L/kg/min.  In this example, no Edi signal was recorded (blue line in the fifth channel).  Instead, a 
trigger signal was attached to the Edi Channel to aid in later analysis. 
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Figure 18: Representative example of synchronised pre-processed EIT signals inserted in to a LabChart file. 
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A.2.4 Example LabChart Macro Recordings 
 
 
Figure 19:  Representative result waveforms from the first LabChart Macro (Macro I: Edi and RIPSUM Analysis). 
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Figure 20:  Representative result waveforms from the second LabChart Macro (Macro II: LLA Analysis). 
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Figure 21:  Representative result waveforms from the third LabChart Macro (Macro III: EIT, Poe and RIPSUM 
Analysis). 
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Figure 22:  Representative result waveforms from the fourth LabChart Macro (Macro IV: RIPSUM, Poe, PRP, 
PTP(di) and PEEPi Analysis). 
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A.3 EIT Results using the EIT Data Analyser 
 
Table 6:  Mean values and absolute mean changes in the Electrical Impedance Tomography measurements taken 
for infants with Bronchiolitis and Cardiac infants, off and on HFNC.  These results were obtained using the 
PCCRG’s standardised EIT data analysis protocol (originally written by me) where calculations were performed 
separately from the main LabChart analysis.  Paired samples t-Tests were used to compare HFNC states within 
groups (*).  An ANOVA was used to compare mean changes between groups (^).  A p-value of <0.05 was 
considered to be statistically significant. 
 
 Bronchiolitis Cardiac Infants Between Groups 
 Off HFNC 
Mean 
On HFNC 
Mean 
Off HFNC 
Mean 
On HFNC 
Mean 
Bronchiolitis 
|Δ Mean| 
Cardiac 
|Δ Mean| 
EELG [∆Z] 
p-value 
-0.016199 
0.062 
0.004180 -0.004803 
0.140 
0.004889 0.020379 
0.595 
0.009692 
EELR [∆Z] 
p-value 
-0.026744 
0.008* 
0.006589 -0.001334 
0.291 
0.007410 0.033333 
0.347 
0.008744 
EELL [∆Z] 
p-value 
-0.011165 
0.262 
-0.000471 -0.002559 
0.070 
0.009087 0.010694 
0.552 
0.011646 
EELA [∆Z] 
p-value 
-0.015730 
0.072 
0.010048 -0.021009 
0.064 
-0.004943 0.025778 
0.433 
0.016066 
EELP [∆Z] 
p-value 
-0.022566 
0.119 
-0.003599 0.008033 
0.276 
0.016832 0.018967 
0.091 
0.008799 
AMPLG [∆Z] 
p-value 
0.031761 
0.032* 
0.026093 0.040290 
0.319 
0.038937 0.005668 
0.076 
0.001353 
AMPLR [∆Z] 
p-value 
0.035737 
0.031* 
0.028537 0.043786 
0.317 
0.042339 0.007200 
0.159 
0.001447 
AMPLL [∆Z] 
p-value 
0.029265 
0.055 
0.024522 0.036353 
0.377 
0.035406 0.004743 
0.133 
0.000947 
AMPLA [∆Z] 
p-value 
0.028403 
0.062 
0.023552 0.038938 
0.265 
0.037032 0.004851 
0.065 
0.001906 
AMPLP [∆Z] 
p-value 
0.041174 
0.012* 
0.032525 0.041632 
0.279 
0.039630 0.008649 
0.562 
0.002002 
ALPHAR [°] 
p-value 
10.351 
0.304 
8.982 5.207 
0.145 
2.872 1.369 
0.064 
2.335 
ALPHAL [°] 
p-value 
-8.967 
0.322 
-10.398 -6.813 
0.151 
-5.047 1.431 
0.320 
1.766 
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ALPHAA [°] 
p-value 
-13.209 
0.280 
-11.291 -3.636 
0.448 
-3.885 1.918 
0.006^ 
0.249 
ALPHAP [°] 
p-value 
11.807 
0.075 
9.249 3.036 
0.077 
-0.556 2.558 
0.013^ 
3.592 
GCGLOBAL [%] 
p-value 
47.523 
0.039* 
45.293 48.189 
0.477 
48.251 2.230 
0.060 
0.063 
GCRIGHT [%] 
p-value 
45.773 
0.020* 
44.163 47.430 
0.465 
47.546 1.610 
0.029^ 
0.116 
GCLEFT [%] 
p-value 
47.481 
0.246 
46.400 47.573 
0.213 
48.758 1.081 
0.349 
1.185 
FIR [Units] 
p-value 
0.893 
0.319 
0.881 0.949 
0.459 
0.948 0.012 
0.050^ 
0.001 
FIL [Units] 
p-value 
1.271 
0.181 
1.342 1.302 
0.160 
1.035 0.071 
0.084 
0.267 
FIA [Units] 
p-value 
1.252 
0.319 
1.223 1.078 
0.021* 
1.034 0.029 
0.005^ 
0.044 
FIP [Units] 
p-value 
0.858 
0.226 
0.868 0.974 
0.041* 
1.001 0.010 
0.018^ 
0.027 
GI INDEX [0-1] 
p-value 
0.422 
0.122 
0.440 0.422 
0.467 
0.420 0.018 
0.538 
0.002 
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Figure 23:  Mean values of the Electrical Impedance Tomography calculations for infants with Bronchiolitis and 
Cardiac infants, off and on HFNC.  Mean and 95% confidence intervals are shown. 
 
 
BN72 Master of Engineering (Research)  Thesis by Monograph 
Trang Pham, 02370701  69 / 77 
A.4 Clinical Findings 
To facilitate the interpretation of results, collected from the clinical HFWOB study, non-
identifiable human data was analysed in collaboration with the PCCRG.  The main results of 
this collaborative analysis, which are relevant to this program of research, are described in 
main body of this thesis.  However, specific findings in relation to the clinical WOB scoring 
component, for both the Bronchiolitis (treatment) and Cardiac (control) groups, are presented 
here.   
A.4.1 The Clinical HFWOB Study 
Between May 2012 and February 2013, the PCCRG enrolled infants in to their HFWOB 
study with 14 recruited in to the Bronchiolitis (treatment) group and 14 recruited in to the 
Cardiac (control) group.  However, only 12 infants from each group had recordings that were 
technically sufficient for analysis. This was generally attributed to the unsettledness of the 
infants following the insertion and adjustment of the Edi catheter, which made it difficult to 
maintain good signal quality.  Regarding the cohorts studied, infants with Bronchiolitis were 
56 days old [44, 72] with a body weight of 5.3 kg [4.6, 5.7] and Cardiac infants were 55 days 
old [18, 96] and with a body weight of 3.8 kg [3.3, 4.6] (median and interquartile range). Two 
of the infants with Bronchiolitis were ex-preterm without chronic lung disease and of the 
Cardiac infants, 9 were post bypass cases and 5 non bypass cases.  The respiratory rate (RR) 
in infants with Bronchiolitis dropped from 60 breaths/min [54, 66] off HFNC to 54 
breaths/min [48, 60] on HFNC (mean and 95% CI, p=0.004) and in Cardiac infants, the RR 
changed from 48 breaths/min [36, 60] to 41 breaths/min [32, 50] (mean and 95% CI, p=ns).   
A.4.2 Clinical WOB Scoring: Results 
The standard clinical scoring system used to assess the WOB and degree of respiratory 
distress in MCH PICU (Table 7), is subjective and based on the clinical experience of the 
observer.  It was not specifically developed for, nor has it been validated for using with 
HFNC.  However, for consistency, standardised WOB assessments for each patient enrolled 
in the clinical HFWOB study were performed by the same experienced Research Nurse, off 
and on HFNC.  To represent these qualitative assessments graphically, WOB categories were 
assigned to a numerical scale (from 0 to 5, where 0 is none and 5 is severe), and plotted 
(Figure 24).   
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Table 7: Respiratory assessment guidelines, as used by clinical staff at the MCH PICU, include observable 
WOB criteria.  Standard assessments are objective and based on the clinical experience of the observer. 
 
Mild Moderate Severe 
 RR within age parameter 
 Minimal accessory muscle 
use (slight ST/IC recession) 
 O2 sats > 93% on RA 
 Normal colour, behaviour 
 RR increased for age group 
 Accessory muscle use has 
increased (retractions also) 
 O2 sats < 93%, supportive 
oxygen required 
 Colour pale/slightly mottled 
 Reduced feeding 
 Irritability, tiredness 
 RR markedly increased for 
age group (tachypnoeic++) 
 Full use of all accessory 
muscles, marked WOB 
 Grunting & head bobbing 
 Apnoeas 
 O2 sats continually < 93% 
despite oxygen support 
 Colour pale >> dusty 
 Refusal to feed/oral intake 
 Lethargy >> fatiguing 
 Diaphoresis 
 Skin temp cool 
 Increased CO2 on Blood Gas 
 
 
Figure 24:  Individual WOB category assessments for infants with Bronchiolitis and Cardiac infants, off and on 
HFNC.  The group means and 95% confidence intervals are also shown. 
 
Overall, the clinical scoring method for assessing WOB and respiratory distress was able to 
show a slight decrease in severity from off HFNC to on HFNC therapy for each group.  
However, within each group, particularly for infants with Bronchiolitis, the individual results 
and the observed parameters used to obtain them (RR and SpO2), demonstrated a large degree 
of variability across the broadly defined categories of WOB (Figure 25). 
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Figure 25:  Observed values of respiratory rate and oxygen saturation, used in the clinical scoring method of 
assessing WOB and respiratory distress, for infants with Bronchiolitis and Cardiac infants, off and on HFNC.   
A.4.3 Clinical WOB Scoring: Discussion 
Clinical WOB scoring utilises the RR as one of the determinants for WOB categories which, 
for the clinical HFWOB study, were conducted by the same experienced Research Nurse for 
each patient, off and on HFNC.  In infants with Bronchiolitis, the RR dropped significantly 
from off HFNC to on HFNC and a similar though not significant drop was also measured in 
the group of Cardiac infants.   While these assessments were able to reflect an overall 
reduction in the WOB for both groups, little distinction could be made regarding the spread of 
individually observed RR values between HFNC states when examined by WOB category.  
Similarly, an overlap of RR values was also observed for the Cardiac infants and in the spread 
of individual oxygen saturation values between HFNC states for both groups.  Clinical WOB 
scoring may be performed quickly by the bedside.  However, even with measurable 
parameters such as the RR and oxygen saturation and the expertise of a consistent and 
experienced observer, there is a still a degree of variability to the results that demands caution 
from the use of clinical scoring systems. 
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